PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells
- PMID: 25819738
- DOI: 10.3109/21691401.2014.982803
PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells
Abstract
Breast cancer is the most frequently occurring cancer among women throughout the world. Natural compounds such as curcumin hold promise to treat a variety of cancers including breast cancer. However, curcumin's therapeutic application is limited, due to its rapid degradation and poor aqueous solubility. On the other hand, previous studies have stated that drug delivery using nanoparticles might improve the therapeutic response to anticancer drugs. Poly(N-isopropylacrylamide-co-methacrylic acid) (PNIPAAm-MAA) is one of the hydrogel copolymers utilized in the drug delivery system for cancer therapy. The aim of this study was to examine the cytotoxic potential of curcumin encapsulated within the NIPAAm-MAA nanoparticle, on the MCF-7 breast cancer cell line. In this work, polymeric nanoparticles were synthesized through the free radical mechanism, and curcumin was encapsulated into NIPAAm-MAA nanoparticles. Then, the cytotoxic effect of curcumin-loaded NIPAAm-MAA on the MCF-7 breast cancer cell line was measured by MTT assays. The evaluation of the results showed that curcumin-loaded NIPAAm-MAA has more cytotoxic effect on the MCF-7 cell line and efficiently inhibited the growth of the breast cancer cell population, compared with free curcumin. In conclusion, this study indicates that curcumin-loaded NIPAAm-MAA suppresses the growth of the MCF-7 cell line. Overall, it is concluded that encapsulating curcumin into the NIPAAm-MAA copolymer could open up new avenues for breast cancer treatment.
Keywords: PNIPAAm-MAA; breast cancer; curcumin; drug delivery.
Similar articles
-
A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line.Cell Mol Biol (Noisy-le-grand). 2016 Aug 29;62(9):51-6. Cell Mol Biol (Noisy-le-grand). 2016. PMID: 27585262
-
Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells.Asian Pac J Cancer Prev. 2014;15(20):8931-6. doi: 10.7314/apjcp.2014.15.20.8931. Asian Pac J Cancer Prev. 2014. PMID: 25374231
-
A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.Artif Cells Nanomed Biotechnol. 2016;44(1):423-30. doi: 10.3109/21691401.2014.955108. Epub 2014 Sep 17. Artif Cells Nanomed Biotechnol. 2016. PMID: 25229832
-
Bioinspired Core-Shell Nanoparticles for Hydrophobic Drug Delivery.Angew Chem Int Ed Engl. 2019 Oct 1;58(40):14357-14364. doi: 10.1002/anie.201908357. Epub 2019 Aug 19. Angew Chem Int Ed Engl. 2019. PMID: 31364258 Review.
-
Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.AAPS J. 2017 Jan;19(1):54-81. doi: 10.1208/s12248-016-0003-2. Epub 2016 Oct 25. AAPS J. 2017. PMID: 27783266 Review.
Cited by
-
NIPAAm-MMA nanoparticle-encapsulated visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis.Oncol Lett. 2018 Apr;15(4):4827-4836. doi: 10.3892/ol.2018.7922. Epub 2018 Feb 1. Oncol Lett. 2018. PMID: 29552122 Free PMC article.
-
Recent Advances in the Antiproliferative and Proapoptotic Activity of Various Plant Extracts and Constituents against Murine Malignant Melanoma.Molecules. 2022 Apr 17;27(8):2585. doi: 10.3390/molecules27082585. Molecules. 2022. PMID: 35458783 Free PMC article. Review.
-
Recent Advances and Disputes About Curcumin in Retinal Diseases.Clin Ophthalmol. 2021 Jun 18;15:2553-2571. doi: 10.2147/OPTH.S306706. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34177257 Free PMC article. Review.
-
Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.Oncotarget. 2017 May 9;8(19):30922-30932. doi: 10.18632/oncotarget.15942. Oncotarget. 2017. PMID: 28427235 Free PMC article.
-
NF-κB signaling in cancer stem cells: a promising therapeutic target?Cell Oncol (Dordr). 2015 Oct;38(5):327-39. doi: 10.1007/s13402-015-0236-6. Epub 2015 Aug 29. Cell Oncol (Dordr). 2015. PMID: 26318853 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical